Overview

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Albumin-Bound Paclitaxel
Axitinib
Bevacizumab
Carboplatin
Paclitaxel